Sponsor content
16 result(s) found, displaying 1 to 10
-
ZYNLONTA loncastuximab tesirine 10 mg powder for concentrate for solution for infusion vial (481165)
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ZYNLONTA loncastuximab tesirine 10 mg powder for concentrate for solution for infusion vial. -
Prescription medicine registrationActive ingredients: pegcetacoplan.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Swedish Orphan Biovitrum Pty Ltd - Mechanically-operated infusion pump set.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Swedish Orphan Biovitrum Pty Ltd - Mechanically-operated infusion pump.
-
Designation or determinationPriority review
-
Designation or determinationOrphan drug
-
Mar-2025Prescription medicine evaluationActive ingredient: loncastuximab tesirine.
-
Prescription medicine registrationActive ingredients: pegcetacoplan.
-
Designation or determinationOrphan drug
-
Designation or determinationProvisional determination